Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS.
Whittemore AS, et al. Among authors: garlinghouse jones k.
Br J Cancer. 2004 Nov 29;91(11):1911-5. doi: 10.1038/sj.bjc.6602239.
Br J Cancer. 2004.
PMID: 15545966
Free PMC article.